Long-term survival of patients undergoing liver transplantation for hepatitis B virus (HBV)-related liver disease has ...

Background A resemblance of pancreatic tumours to their native tissue architecture remains largely unexplored, while it may ...

Duodenoscope-associated infections remain a safety concern, and single-use duodenoscopes have been introduced to mitigate ...

8 Women's and Children's Hospital, South Australia, Australia Objective The purpose of this study was the clinical and pathological characterisation of a new autosomal dominant gastric polyposis ...

Despite the transformative impact of immune checkpoint inhibitors in oncology, hepatocellular carcinoma (HCC) remains stubbornly resistant in many patients, with durable responses to combination ...

Background Long-term adherence and results with faecal immunochemical test (FIT)-based colorectal cancer (CRC) screening are poorly characterised. Objective To characterise adherence and results ...

Chronic hepatitis D (CHD) is the most severe form of viral hepatitis, carrying a greater risk of developing cirrhosis and its complications. For decades, pegylated interferon alpha (PegIFN-α) has ...

Objective Biological therapies and small molecules continue to be evaluated in moderate to severely active ulcerative colitis, but are often studied in placebo-controlled trials, meaning their ...

3 Department of Paediatrics, Meander Medisch Centrum, Amersfoort, the Netherlands 4 MediServ BV/Clinical Research facilities BV, Schaijk, the Netherlands Correspondence to: Dr W P Voskuijl Department ...

Background Hepatocellular carcinoma (HCC), one of the most prevalent cancers worldwide, has a high mortality owing to diagnostic challenges and therapeutic resistance. Lactate metabolism and protein ...

Background Effect of glycaemic control on pancreatic cancer (PC) development in patients with long-standing type 2 diabetes (T2D) remains unclear. Objective To investigate effects of glycaemic control ...

Objectives As part of the International Cancer Benchmarking Partnership (ICBP) SURVMARK-2 project, we provide the most recent estimates of colon and rectal cancer survival in seven high-income ...